CA
HCA icon

Crewe Advisors’s HCA Healthcare HCA Stock Holding History

Crewe Advisors’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7K Buy
30
+17
+131% +$7.19K ﹤0.01% 728
2026
Q1 		$6.15K Buy
13
+6
+86% +$3.02K ﹤0.01% 738
2025
Q4 		$3.27K Buy
+7
New +$3.25K ﹤0.01% 802
2025
Q3 		– Sell
-2
Closed -$767 – 1001
2025
Q2 		$767 Buy
2
+1
+100% +$360 ﹤0.01% 629
2025
Q1 		$346 Sell
1
-1
-50% -$322 ﹤0.01% 658
2024
Q4 		$601 Sell
2
-35
-95% -$12.2K ﹤0.01% 544
2024
Q3 		$15K Buy
37
+2
+6% +$732 ﹤0.01% 435
2024
Q2 		$11.2K Sell
35
-27
-44% -$8.77K ﹤0.01% 669
2024
Q1 		$20.7K Buy
+62
New +$18.9K ﹤0.01% 486
2023
Q3 		– Sell
-1
Closed -$304 – 728
2023
Q2 		$304 Buy
+1
New +$278 ﹤0.01% 673
2022
Q4 		– Sell
-65
Closed -$12K – 1124
2022
Q3 		$12K Buy
65
+23
+55% +$4.58K ﹤0.01% 608
2022
Q2 		$7K Buy
+42
New +$9.02K ﹤0.01% 689
2020
Q4 		– Sell
-33
Closed -$4K – 541
2020
Q3 		$4K Buy
+33
New +$4.08K ﹤0.01% 396

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Crewe Advisors's HCA Position: Q2 2026 in Review

Crewe Advisors increased its HCA Healthcare (HCA) stake by 131% in Q2 2026, buying an estimated $7.19K and bringing the position to 30 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #728.

Crewe Advisors first reported a position in HCA in Q3 2020 and has held it in 13 quarters since. The position peaked at $20.7K in Q1 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Crewe Advisors held 30 shares of HCA Healthcare worth $11.7K as of Q2 2026.
  • Crewe Advisors bought 17 HCA Healthcare shares in Q2 2026, an estimated $7.19K.
  • HCA Healthcare made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #728 holding.
  • Crewe Advisors first reported a position in HCA Healthcare in Q3 2020 and has held it in 13 quarters since.
  • Crewe Advisors's HCA Healthcare position peaked at $20.7K in Q1 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.